Congo vs Guinea: The number of people with susceptibility test result for rifampicin
Congo
42.71
in 2021
Guinea
44.93
in 2021
Congo rank
122nd
Guinea rank
120th
The number of people with susceptibility test result for rifampicin over time
- Congo
- Guinea
How they compare
Guinea currently reports 44.93 against 42.71 in Congo, a difference of 2.22.
That makes Guinea's figure about 1.1 times Congo's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Guinea ahead.
Congo ranks 122nd and Guinea ranks 120th of 146 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Guinea in 1.
Head to head by decade
| Decade | Congo | Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 15.4 | 17.48 | 2.08 | Guinea |
| 2020s | 71.35 | 23.42 | 47.94 | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Congo or Guinea?
- Guinea, at 44.93 against 42.71 in Congo as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Congo and Guinea?
- 2.22, with Guinea ahead.
- How many years of comparable data are there for Congo and Guinea?
- 5 years are reported by both, from 2017 to 2021.
- How do Congo and Guinea rank globally for the number of people with susceptibility test result for rifampicin?
- Congo ranks 122nd and Guinea ranks 120th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.